Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong, S Lim… - Cancer biology & …, 2016 - Taylor & Francis
Compound EGFR mutations, defined as double or multiple mutations in the EGFR tyrosine
kinase domain, are frequently detected with advances in sequencing technology but its …
kinase domain, are frequently detected with advances in sequencing technology but its …
Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong… - CANCER …, 2016 - repository.hanyang.ac.kr
Compound EGFR mutations, defined as double or multiple mutations in the EGFR tyrosine
kinase domain, are frequently detected with advances in sequencing technology but its …
kinase domain, are frequently detected with advances in sequencing technology but its …
[引用][C] CompoundEGFRmutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong, S Lim… - Cancer Biology & …, 2016 - cir.nii.ac.jp
Compound<i>EGFR</i>mutation is frequently detected with co-mutations of actionable genes
and associated with poor clinical outcome in lung adenocarcinoma | CiNii Research CiNii 国立 …
and associated with poor clinical outcome in lung adenocarcinoma | CiNii Research CiNii 国立 …
[HTML][HTML] Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong, S Lim… - Cancer Biology & …, 2016 - ncbi.nlm.nih.gov
Compound EGFR mutations, defined as double or multiple mutations in the EGFR tyrosine
kinase domain, are frequently detected with advances in sequencing technology but its …
kinase domain, are frequently detected with advances in sequencing technology but its …
[PDF][PDF] Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong, S Lim… - CANCER BIOLOGY & …, 2016 - core.ac.uk
Despite relentless efforts to decrease the mortality of lung cancer, it remains a common and
leading cause of cancer-related death worldwide. In the year 2012, 1,824,701 new cases …
leading cause of cancer-related death worldwide. In the year 2012, 1,824,701 new cases …
Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong… - Cancer biology & …, 2016 - pubmed.ncbi.nlm.nih.gov
Compound EGFR mutations, defined as double or multiple mutations in the EGFR tyrosine
kinase domain, are frequently detected with advances in sequencing technology but its …
kinase domain, are frequently detected with advances in sequencing technology but its …
Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong, S Lim… - Cancer Biology and …, 2016 - pure.ewha.ac.kr
Compound EGFR mutations, defined as double or multiple mutations in the EGFR tyrosine
kinase domain, are frequently detected with advances in sequencing technology but its …
kinase domain, are frequently detected with advances in sequencing technology but its …
Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong… - Cancer Biology and …, 2016 - scholarworks.bwise.kr
Compound EGFR mutations, defined as double or multiple mutations in the EGFR tyrosine
kinase domain, are frequently detected with advances in sequencing technology but its …
kinase domain, are frequently detected with advances in sequencing technology but its …
Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma.
EY Kim, EN Cho, HS Park, JY Hong, S Lim… - Cancer Biology & …, 2016 - europepmc.org
Compound EGFR mutations, defined as double or multiple mutations in the EGFR tyrosine
kinase domain, are frequently detected with advances in sequencing technology but its …
kinase domain, are frequently detected with advances in sequencing technology but its …
Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma
EY Kim, EN Cho, HS Park, JY Hong, S Lim, JP Youn… - 2016 - ir.ymlib.yonsei.ac.kr
Compound EGFR mutations, defined as double or multiple mutations in the EGFR tyrosine
kinase domain, are frequently detected with advances in sequencing technology but its …
kinase domain, are frequently detected with advances in sequencing technology but its …